Alyssa Levin
Direttore Finanziario/CFO presso NKARTA, INC.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Alyssa Levin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NKARTA, INC. | Direttore Finanziario/CFO | 05/07/2023 | - |
Storia della carriera di Alyssa Levin
Precedenti posizioni note di Alyssa Levin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Direttore Finanziario/CFO | - | 05/07/2023 |
Formazione di Alyssa Levin
| University of British Columbia | Undergraduate Degree |
| Edwards School of Business | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Canada | 3 |
Posizioni
| Director of Finance/CFO | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NKARTA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Alyssa Levin
- Esperienza
